Voyager Therapeutics Inc’s recently made public that its Chief Scientific Officer Carter Todd Alfred unloaded Company’s shares for reported $14079.0 on Feb 20 ’25. In the deal valued at $4.26 per share,3,305 shares were sold. As a result of this transaction, Carter Todd Alfred now holds 77,718 shares worth roughly $0.26 million.
Then, Sandrock Alfred sold 11,702 shares, generating $49,616 in total proceeds. Upon selling the shares at $4.24, the President and CEO now owns 296,816 shares.
Before that, Swartz Robin sold 3,894 shares. Voyager Therapeutics Inc shares valued at $16,550 were divested by the COO & CBO at a price of $4.25 per share. As a result of the transaction, Swartz Robin now holds 98,397 shares, worth roughly $0.33 million.
Cantor Fitzgerald initiated its Voyager Therapeutics Inc [VYGR] rating to an Overweight in a research note published recently. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. Leerink Partners started covering the stock on October 16, 2024. It rated VYGR as “an Outperform”.
Price Performance Review of VYGR
On Tuesday, Voyager Therapeutics Inc [NASDAQ:VYGR] saw its stock fall -0.30% to $3.37. Over the last five days, the stock has lost -9.41%. Voyager Therapeutics Inc shares have fallen nearly -40.56% since the year began. Nevertheless, the stocks have fallen -63.80% over the past one year. While a 52-week high of $10.66 was reached on 01/07/25, a 52-week low of $3.36 was recorded on 04/01/25. SMA at 50 days reached $4.46, while 200 days put it at $6.25.
Levels Of Support And Resistance For VYGR Stock
The 24-hour chart illustrates a support level at 3.27, which if violated will result in even more drops to 3.16. On the upside, there is a resistance level at 3.47. A further resistance level may holdings at 3.56. The Relative Strength Index (RSI) on the 14-day chart is 28.49, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.32, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.62%. Stochastics %K at 8.10% indicates the stock is a buying.
How much short interest is there in Voyager Therapeutics Inc?
A steep rise in short interest was recorded in Voyager Therapeutics Inc stocks on 2025-03-14, growing by 96393.0 shares to a total of 2.81 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 2.72 million shares. There was a rise of 3.42%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 26, 2024 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $22 price target.
